JPRN-UMIN000045735招募中未知
Research on therapeutic drugs for celiac disease - Research on therapeutic drugs for celiac disease
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of known Immunoglobulin E -mediated reaction to wheat, barley or Rye 2.Unable to provide documentation of duodenal histology that reports villous atrophy, and of elevated serum transglutaminase-specific IgA, IgA endomysial immunofluorescence (EMA), or for IgA deficient individuals then DGP IgG. 3.Medication within 3 months that might suppress cellular immunity (e.g. oral or parental corticosteroids, immunosuppressive medication) 4.Any medical condition that in the opinion of the investigator may interfere with study conduct. 5.Any medical condition that in the opinion of the investigator would impact the immune response, confound interpretation of study results, or pose an increased risk to the patient. 6.Haemoglobin level or platelet count at screening that is outside the normal gender-specific and age-specific range 7.Individual has uncontrolled medical conditions that in the opinion of the investigator, would increase the risk of blood collection to the patient. For guidance see American Red Cross Blood Donation eligibility criteria 8.Blood donation (one unit of blood) within the previous 8 weeks. 9.Heart disease with heart related symptoms. 10.Heart murmur, or heart valve disorder that has not been medically evaluated, or has caused symptoms within the last 6 months, and is associated with restrictions on normal daily activities. 11.Any medical condition or therapy resulting in impaired blood clotting and bleeding. 12.Body weight less than 50 kg. 13.The pregnant. 14.Vital signs outside the range: systolic blood pressure 90 to 180 mm Hg, diastolic blood pressure 60 to 100 mm Hg, pulse rate regular and 50 to 100 per minute, or body temperature exceeding 99.5oF.
研究者
相似试验
已完成
不适用
Celiac Disease and Diabetes- Dietary Intervention and Evaluation TrialDiabetes Mellitus, Type 1Celiac DiseaseNCT01566110The Hospital for Sick Children50
进行中（未招募）
不适用
Exploration clinique, biologique et pharmacologique d'un polymorphisme de NEDD 4-2, protéine régulatrice du canal sodium épithélial - JEU004Etude chez des sujets normovolontaires dont le but est de détecter d'éventuelles anomalies de réabsorption sodée qui soient la conséquence du polymorphisme de la protéine Nedd4-2.EUCTR2006-005056-32-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
进行中（未招募）
不适用
Clinical trials in rare diseases: therapeutic alternative to the use of oral corticosteroids in patients with cystic fibrosis underwent double lung transplantation.Double lung transplantation in patients with Cystic FibrosisMedDRA version: 14.1Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.1Level: PTClassification code 10025127Term: Lung transplantSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-000130-11-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
已完成
不适用
Clinical trial aimed at new therapeutic approch against HAM patients by pentosan polysulphateHTLV-I associated myelopathy (HAM)JPRN-UMIN000004492Department of Molecular Microbilogy and Immunology15
招募中
2 期
A clinical trial to evaluate the effect of an Ayurvedic medicine, varyadi kashaya in patients with raised blood levels of uric acid.CTRI/2023/03/050452INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT S.V.S.P.